A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
Study sponsor: PTC Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-08-29Actual
Enrollment · participants5Actual
Source updated2025-08-22Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.